Why Nilotinib Is Considered a Targeted Therapy
Unlike conventional cytotoxic chemotherapy, nilotinib targets abnormal **BCR-ABL tyrosine kinase activity** associated with CML cells. This targeted mechanism makes terms such as Nilotinib targeted therapy and "BCR-ABL inhibitor"** relevant when researching the medicine.Why Choose Ernest Oncology?
Ernest Oncology focuses on oncology pharmaceutical sourcing for eligible distributors, licensed importers, wholesalers and institutional healthcare procurement organisations.Frequently Asked Question
Contact Ernest Oncology
Official Websites
π www.oncologymedicinesupplier.com
WhatsApp
π± +91 93599 02383
Chat with Us on WhatsApp
π¬ https://wa.me/919359902383